Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody

Journal of Lipid Research

Volumn 37, Issue 1, 1996, Pages 45-53

  Itabe, Hiroyuki ^a   Yamamoto, Hisashi ^a   Imanaka, Tsuneo ^a   Shimamura, Kyoko ^b   Uchiyama, Hideki ^b   Kimura, Junji ^b   Sanaka, Tsutomu ^c   Hata, Yoshiya ^d   Takano, Tatsuya ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b Vessel Research Laboratory Inc   (Japan)

^c Tokyo Women's University   (Japan)

^d KYORIN UNIVERSITY   (Japan)

Author keywords

hemodialysis; LDL oxidation levels in human plasma; monoclonal antibody; oxidized LDL; renal dysfunction; sandwich ELISA

Indexed keywords

LOW DENSITY LIPOPROTEIN; MONOCLONAL ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CONFORMATIONAL TRANSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LIPID ANALYSIS; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; APOLIPOPROTEINS B; BINDING, COMPETITIVE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; PHOSPHATIDYLCHOLINES;

EID: 0030053467     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Steinbrecher, U. P., S. Parthasarathy, D. S. Leake, J. L. Witztum, and D. Steinberg. 1984. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA. 81: 3883-3887.
2. Carew, T. E., D. C. Schwenke, and D. Steinberg. 1987. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of highperlipidemic rabbit. Proc. Natl. Acad. Sci. USA. 84: 7725-7729.
3. Sasaki, T., T. Tanishima, T. Asano, Y. Mayanagi, and K. Sano. 1979. Significance of lipid peroxidation in the genesis of chronic vasospasm following rupture of an intracranial aneurysm. Acta Neurochir. (Suppl.) 28: 536-540.
4. Yoshikawa, T., K. Yamaguchi, M. Kondo, N. Mizukawa, T. Ohta, and K. Hirakawa. 1982. Thiobarbituric acid reactive substances and vitamin E in serum and cerebrospinal fluid from patients with cerebral apoplexy. Arch. Gerontol. Geriatr. 1: 209-218.
5. Fillit, H., E. Elion, J. Sullivan, R. Sherman, and J. B. Zabriskie. 1981. Thiobarbituric acid reactive materials in uremic blood. Nephron. 29: 40-43.
6. Gröne, E. F., A. K. Walli, H-J. Gröne, B. Miller, and D. Seidel. 1994. The role of lipids in nephrosclerosis and glomerulosclerosis. Atherosclerosis. 107: 1-13.
7. Sato, Y., N. Hotta, N. Sakamoto, S. Matsuoka, N. Ohishi, and K. Yagi. 1979. Lipid peroxide level in plasma of diabetic patients. Biochem. Med. 21: 104-107.
8. Asayama, K., H. Hayashibe, K. Dobashi, T. Niitsu, A. Miyao, and K. Kato. 1989. Antioxidant enzyme status and lipid peroxidation in various tissues of diabetic and starved rats. Diabetes Res. 12: 85-91.
9. Witztum, J. L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
10. Palinski, W., M. E. Rosenfeld, S. Ylä-Herttuala, G. C. Gurtner, S. S. Socher, S. W. Butler, S. Parthasarathy, T. E. Carew, D. Steinberg, and J. L. Witztum. 1989. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86: 1372-1376.
11. Rosenfeld, M. E., J. C. Khoo, E. Miller, S. Parthasarathy, W. Palinski, and J. L. Witztum. 1991. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J. Clin. Invest. 87: 90-99.
12. 1 and destruxin E. Biochim. Biophys. Acta. 1126: 41-48.
13. Lougheed, M., H. Zhang, and U. P. Steinbrecher. 1991. Oxidized low density lipoprotein is resistant to cathepsins and accumulates within macrophages. J. Biol. Chem. 266: 14519-14525.
14. Lehr, H. A., C. Hübner, B. Finckh, S. Angermüller, D. Nolte, U. Beisiegel, A. Kohlschütter, and K. Messmer. 1991. Role of leukotriens in leukocyte adhesion following systemic administration of oxidatively modified human low density lipoprotein in hamsters. J. Clin. Invest. 88: 9-14.
15. Jeng, J-R., C-H. Chang, S-M. Shieh, and H-C. Chiu. 1993. Oxidized low density lipoprotein enhances monocyte-endothelial cell binding against shear-stress-induced detachment. Biochim. Biophys. Acta. 1178: 221-227.
16. Murugesan, G., G. M. Chisolm, and P. L. Fox. 1993. Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro. J. Cell Biol. 120: 1011-1019.
17. Boulanger, C. M., F. C. Tanner, M-L. Béa, A. W. A. Hahn, A. Werner, and T. F. Lúscher. 1992. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ. Res. 70: 1191-1197.
18. Martin-Nizard, F., H. S. Houssaini, S. Lestavel-Delattre, P. Duriez, and J-C. Fruchart. 1991. Modified low density lipoproteins activate human macrophages to secrete immunoreactive endothelin. FEBS Lett. 293: 127-130.
19. Ylä-Herttuala, S., W. Palinski, M. E. Rosenfeld, S. Parthasarathy, T. E. Carew, S. Butler, J. L. Witztum, and D. Steinberg. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095.
20. Itabe, H., E. Takeshima, H. Iwasaki, J. Kimura, Y. Yoshida, T. Imanaka, and T. Takano. 1994. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines andpolypeptides. J. Biol. Chem. 269: 15274-15279.
21. Redgrave, T. G., D. C. K. Roberts, and C. E. West. 1975. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal. Biochem. 65: 42-49.
22. Bronzert, T. J., and H.B. Brewer, Jr. 1977. New micromethod for measuring cholesterol in plasma lipoprotein fractions. Clin. Chem. 23: 2089-2098.
23. Smith, P. K., R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150: 76-85.
24. Abele, J., and H. Khayam-Bashi. 1979. Aqueous primary standard for use in measuring cholesterol by the cholesterol oxidase method. Clin. Chem. 25: 132-135.
25. Buege, J. A., and S. D. Aust. 1978. Microsomal lipid peroxidation. Methods Enzymol. 52: 303-310.
26. Noble, R. P. 1968. Electrophoretic separation of plasma lipoproteins in agarose gel. J. Lipid Res. 9: 693-700.
27. Zhou, X., and G. Arthur. 1992. Improved procedures for the determination of lipid phosphorus by malachite green. J. Lipid Res. 33: 1233-1236.
28. Freeman, M., Y. Ekkel, L. Rohrer, M. Penman, N. J. Freedman, G. M. Chisolm, and M. Krieger. 1991. Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA. 88: 4931-4935.
29. Endemann, G., L. W. Stanton, K. S. Maddem, C. M. Bryant, R. T. White, and A. A. Protter. 1993. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 269: 11811-11816.
30. Haberland, M. E., D. Fong, and L. Cheng. 1988. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science. 214: 215-218.
31. Rosenfeld, M. E., W. Palinski, S. Ylä-Herttuala, S. Butler, and J. L. Witztum. 1990. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis. 10: 336-349.
32. Kotani, K., M. Maekawa, T. Kanno, A. Kondo, N. Toda, and M. Manabe. 1994. Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum. Biochim. Biophys. Acta. 1215: 121-125.
33. Parums, D. V., D. L. Brown, and M. J. Mitchinson. 1990. Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. Arch. Pathol. Lab. Med. 114: 383-387.
34. Salonen, J. T., S. Ylä-Herttuala, R. Yamamoto, S. Butler, H. Korpela, R. Salonen, K. Nyyssönen, W. Palinski, and J. L. Witztum. 1992. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet. 339: 883-887.
35. van Goor, H., M. L. C. van der Horst, J. Atmossoerodjo, J. A. Joles, A. van Tol, and J. Grond. 1993. Renal apolipoproteins in nephrotic rats. Am. J. Pathol. 142: 1804-1812.
36. Magil, A. B., J. J. Frohlich, S. M. Innis, and U. P. Steinbrecher. 1993. Oxidized low-density lipoprotein in experimental focal glomerulosclerosis. Kidney Int. 43: 1243-1250.
37. Schettler, V., E. Wieland, R. Verwiebe, P. Schuff-Werner, F. Scheler, and M. Oellerich. 1994. Plasma lipids are not oxidized during hemodialysis. Nephron. 67: 42-47.
38. Loughrey, C. M., I. S. Young, J. McEnerry, I. F. W. McDowell, C. McMaster, P. T. McNamee, and E. R. Trimble. 1994. Oxidation of low density lipoprotein in patients on regular haemodialysis. Atherosclerosis. 110: 185-193.
39. Zochée, P., R. Daelemans, P. Pollaris, M. A. Boogaerts, and R. L. Lins. 1994. Neutrophil adhesion molecules in chronic hemodialysis patients. Nephron. 68: 192-196.
40. Combe, C., M. Pourtein, V. de Précigout, A. Baquey, D. Morel, L. Potaux, P. Vincendeau, J. H. Bézian, and M. Aparicio. 1994. Granulocyte activation and adhesion molecules during hemodialysis with cuprophane and a high-flux biocompatible membrane. Am. J. Kidney Dis. 24: 437-442.